Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adrenal incidentaloma: A puzzle for clinician.
Jain SM. Jain SM. Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S59-63. doi: 10.4103/2230-8210.119507. Indian J Endocrinol Metab. 2013. PMID: 24251222 Free PMC article. Review.
Diabetes insipidus: The other diabetes.
Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, Thomas N, Unnikrishnan AG, Thakkar PB, Malve H. Kalra S, et al. Among authors: jain sm. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):9-21. doi: 10.4103/2230-8210.172273. Indian J Endocrinol Metab. 2016. PMID: 26904464 Free PMC article. Review.
Barriers and solutions to diabetes management: An Indian perspective.
Wangnoo SK, Maji D, Das AK, Rao PV, Moses A, Sethi B, Unnikrishnan AG, Kalra S, Balaji V, Bantwal G, Kesavadev J, Jain SM, Dharmalingam M. Wangnoo SK, et al. Among authors: jain sm. Indian J Endocrinol Metab. 2013 Jul;17(4):594-601. doi: 10.4103/2230-8210.113749. Indian J Endocrinol Metab. 2013. PMID: 23961474 Free PMC article.
Type 1 diabetes: Awareness, management and challenges: Current scenario in India.
Kumar KM, Saboo B, Rao PV, Sarda A, Viswanathan V, Kalra S, Sethi B, Shah N, Srikanta SS, Jain SM, Raghupathy P, Shukla R, Jhingan A, Chowdhury S, Jabbar PK, Kanungo A, Joshi R, Kumar S, Tandon N, Khadilkar V, Chadha M. Kumar KM, et al. Among authors: jain sm. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1):S6-8. doi: 10.4103/2230-8210.155339. Indian J Endocrinol Metab. 2015. PMID: 25941655 Free PMC article.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide as add-on to sodium-glucose co-transporter-2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA-ADD2SGLT2i, a 26-week, randomized, double-blind, placebo-controlled trial.
Blonde L, Belousova L, Fainberg U, Garcia-Hernandez PA, Jain SM, Kaltoft MS, Mosenzon O, Nafach J, Palle MS, Rea R. Blonde L, et al. Among authors: jain sm. Diabetes Obes Metab. 2020 Jun;22(6):929-937. doi: 10.1111/dom.13978. Epub 2020 Feb 14. Diabetes Obes Metab. 2020. PMID: 31984646 Free PMC article. Clinical Trial.
98 results